2016
DOI: 10.1210/jc.2016-2728
|View full text |Cite
|
Sign up to set email alerts
|

Vascular Disease Is Associated With the Expression of Genes for Intestinal Cholesterol Transport and Metabolism

Abstract: Intestinal cholesterol metabolism gene expression is significantly associated with postprandial increment in triglycerides, intestinal ApoB48, and reduced postprandial FMD. Some genes were also associated with increased IMT. These findings suggest a role of intestinal cholesterol metabolism in development of early vascular disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 41 publications
(32 reference statements)
0
2
0
Order By: Relevance
“…Consistent with our findings, expression of Npc1l1 and sterol absorption are increased by glucose 35,40 and nuclear levels of SREBF2 are increased by feeding and insulin 41 . Inhibition by SHP of other known SHPinteracting factors whose binding motifs were detected in the Npc1l1 promoter, such as, LRH-1 or AhR 14,36 , may contribute to Npc1l1 repression, but SHP inhibition of SREBF2 is likely primary, given the importance of SREBF2 in the regulation of Npc1l1 and sterol levels [35][36][37][38] .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Consistent with our findings, expression of Npc1l1 and sterol absorption are increased by glucose 35,40 and nuclear levels of SREBF2 are increased by feeding and insulin 41 . Inhibition by SHP of other known SHPinteracting factors whose binding motifs were detected in the Npc1l1 promoter, such as, LRH-1 or AhR 14,36 , may contribute to Npc1l1 repression, but SHP inhibition of SREBF2 is likely primary, given the importance of SREBF2 in the regulation of Npc1l1 and sterol levels [35][36][37][38] .…”
Section: Discussionmentioning
confidence: 99%
“…Binding motifs for several factors, including SREBFs, were identified in these regions ( Figure 6A, left). Since multiple SREs were detected at the Npc1l1 gene promoter, intestinal expression of Npc1l1 is activated by SREBF2 and to a much lesser extent by SREBF1 [35][36][37] , and SREBF2 expression strongly correlates with NPC1L1 expression in hyperlipidemia patients 38 , we focused mechanistic studies on SREBF2.…”
Section: Srebf2 Activation Of Expression Of Npc1l1 In Intestinal Cellmentioning
confidence: 99%